Kromek Group plc, a developer of radiation and bio-detection technology solutions has reported a huge increase in half-year results.

For the six months ended 31st October 2025, revenue increased substantially to £15m (H1 2025: £3.7m) at the North East firm.

Adjusted EBITDA was £6m (H1 2025: £2.3m loss) while profit before tax was £3.1m (H1 2025: £5.7m loss).

Cash and cash equivalents at 31st October 2025 were £1.2m (30th April 2025: £1.7m) while the company secured a revolving credit facility of £6m – of which £1m had been drawn as at 31st October 2025 – during the period. It also secured a £500,000 asset finance facility.